Impact of isolation in patients with IBD during the CoViD-19 Crisis [COVID-19]
Research type
Research Study
Full title
Impact of isolation in patients with IBD during the 2020 CoViD-19 Crisis: a mixed methods study
IRAS ID
284243
Contact name
Alan Lobo
Contact email
Sponsor organisation
Sheffield Teaching Hospitals NHS FT
Duration of Study in the UK
1 years, 11 months, 30 days
Research summary
The coronavirus pandemic has changed healthcare dramatically in a short time. Individuals with chronic illnesses and services for them have had to adapt and change to deal with requirements for shielding and social isolation to reduce infection risk and management of medication investigation and ongoing review. \n\nIt is increasingly recognised that the pandemic and the changes to daily life will have had a series of impacts on patients and health care services, including impacts on patients psychological well-being and the opportunity to seek medical care for non-CoViD illness. \n\nPsychological symptoms such as depression, anxiety and hopelessness is well described in adults and young people with IBD. Quarantine has also been associated with these psychological symptoms and also post-traumatic stress. It is important to identify the extent of and factors that influence negative psychological consequences of isolation in patients with IBD.\n\nThis study will aim to assess what impact the isolation of patients during social isolation had in terms of psychological well-being – and what are the factors affecting this impact, particularly in younger and old age groups.\n
REC name
Wales REC 2
REC reference
20/WA/0178
Date of REC Opinion
25 Jun 2020
REC opinion
Further Information Favourable Opinion